Phase 3 Immunisation Clinical Trials
3 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–3 of 3 trials
Recruiting
Phase 2Phase 3
A Seamless Phase II/III, Observer-blind, to Evaluate Immunogenicity and Safety of Chikungunya Virus Vaccine in Healthy Subjects 12-65Years of Age.
Active Immunisation for Chikungunya Virus Infection
Bharat Biotech International Limited1,000 enrolled10 locationsNCT07555392
Recruiting
Phase 3
Second Dose of Varicella Vaccine in Healthy Children
Varicella (Chickenpox)Varicella Immunisation
Sinovac (Dalian) Vaccine Technology Co., Ltd.300 enrolled5 locationsNCT07475000
Recruiting
Phase 3
RSV Immunogenicity Study in the Elderly (RISE)
RSV Immunisation
Karin Karin Loré65 enrolled2 locationsNCT07203365